Trial Summary
What is the purpose of this trial?Exposure-based cognitive behavior therapy is an efficacious treatment for speech anxiety and has been delivered effectively in a virtual reality (VR) environment. The present multicenter study (conducted through the Exposure Therapy Consortium) is designed to evaluate whether trait versus state positive affectivity is a more effective predictor of exposure therapy outcomes. Further, the investigators will examine whether the predictive significance of trait positive affectivity can be accounted for by examination of baseline levels of self-efficacy, hope, and optimism.
Eligibility Criteria
This trial is for individuals with anxiety disorders, specifically those who experience speech anxiety or social anxiety disorder. Participants should be comfortable using virtual reality (VR) technology as the intervention involves a single-session VR exposure.Treatment Details
The study tests if a one-time virtual reality session can help reduce speech anxiety. It also explores whether long-term personality traits or temporary emotional states better predict how well people will respond to this VR therapy.
1Treatment groups
Experimental Treatment
Group I: Positive or Negative Mood Induction via film clipsExperimental Treatment1 Intervention
VR exposure is the only intervention, but the VR intervention is conducted following either positive or negative mood induction.
Find a clinic near you
Research locations nearbySelect from list below to view details:
Boston UniversityBoston, MA
Loading ...
Who is running the clinical trial?
Boston University Charles River CampusLead Sponsor
The University of Hong KongCollaborator
University of Texas at AustinCollaborator
Tufts UniversityCollaborator
The University of New South WalesCollaborator
Curtin UniversityCollaborator
Erasmus University RotterdamCollaborator
University of Western SydneyCollaborator
National University of SingaporeCollaborator
Philipps Universität MarburgCollaborator